إعلان
إعلان
CASI
CASI Pharmaceuticals, Inc. Ordinary Shares
1.08
USDبرعاية
+0.02
+1.88%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.09
+0.01
+0.92%
تقارير أرباح CASI
النسبة الإيجابية المفاجئة
CASI تفوق 19 من 36 آخر التقديرات.
53%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.36
التغير الضمني من Q3 25 (Revenue/ EPS)
-100.00%
/-46.27%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/--
CASI Pharmaceuticals, Inc. Ordinary Shares earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, CASI reported earnings of -0.67 USD per share (EPS) for Q3 25, missing the estimate of -0.40 USD, resulting in a -64.22% surprise. Revenue reached 3.08 مليون, compared to an expected --, with a 0.00% difference. The market reacted with a -5.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.36 USD, with revenue projected to reach -- USD, implying an نقصان of -46.27% EPS, and نقصان of -100.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were CASI Pharmaceuticals, Inc. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CASI Pharmaceuticals, Inc. Ordinary Shares reported EPS of -$0.67, missing estimates by -64.22%, and revenue of $3.08M, 0% as expectations.
How did the market react to CASI Pharmaceuticals, Inc. Ordinary Shares's Q3 2025 earnings?
The stock price moved down -5.56%, changed from $1.26 before the earnings release to $1.19 the day after.
When is CASI Pharmaceuticals, Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for CASI Pharmaceuticals, Inc. Ordinary Shares's next earnings report?
Based on 3
المحللين, CASI Pharmaceuticals, Inc. Ordinary Shares is expected to report EPS of -$0.36 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان